Hedge Fund Manager Attacked Over Biotech Stock Short Sales
A government watchdog group on Monday asked the U.S. Attorney in New York City to investigate a hedge fund manager over allegations that he manipulated the price of biotechnology and pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article